IDH1 and glioma: IDH1-R132H (mIDH1) catalyzes the production of 2-hrydroxyglutarate, eliciting epigenetic reprogramming of gene expression (33, 40, 43, 44) and is associated with better prognosis in glioma patients (33, 39, 40, 45).